Microbiome therapeutics
Beschreibung
Development of a novel two-step process for the production of next Generation microbiome therapeutics. We will develop an innovative, two step production technology for consortia of strict anaerobic gut bacteria. This will be the first GMP grade, large scale production process in the gut microbiome field, resulting in viable, highly efficient and stable microbial products.
Eckdaten
Projektleitung
Prof. Dr. Dieter Eibl, Dr. Florian Rosenthal
Stellv. Projektleitung
Projektteam
Projektpartner
PharmaBiome AG
Projektstatus
abgeschlossen, 05/2018 - 12/2020
Institut/Zentrum
Institut für Chemie und Biotechnologie (ICBT)
Drittmittelgeber
Innovationsprojekt / Projekt Nr. 27873.1 PFLS-LS
Projektvolumen
19'665 CHF